Vas Narasimhan-Anthropic Appointment

Anthropic appointed Vas Narasimhan to its board on April 14, 2026, making him the first pharmaceutical industry executive to join the AI startup’s governing body. Critically, he was appointed by the Anthropic Long-Term Benefit Trust an independent body whose members have no financial stake in Anthropic, and with his addition, Trust-appointed directors now make up a majority of the board. This is a clear and strong governance signal.A signal for what? Listen to this podcast for more on the topic. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com